Trials / Completed
CompletedNCT02832089
Oral Carvedilol in Escalating Doses in the Acute Treatment of Atrial Fibrillation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Andhra Medical College · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Oral carvedilol administered in escalating doses in patients with atrial fibrillation among patients with AF with fast ventricular rate.
Detailed description
Patients with AF with FVR of any etiology were evaluated and given escalating doses of oral carvedilol in doses - 3.125mg OD, then 3.125 bid, then 6.25mg bid, then 12.5mg bid. The ECG was recorded regularly and analysed for rate reduction or control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral carvedilol | oral carvedilol in escalating doses for reducing ventricular rate in AF patients |
Timeline
- Start date
- 2000-12-01
- Primary completion
- 2002-03-01
- Completion
- 2002-03-01
- First posted
- 2016-07-14
- Last updated
- 2016-07-14
Source: ClinicalTrials.gov record NCT02832089. Inclusion in this directory is not an endorsement.